- The study investigated the effectiveness of post-operative chemoradiotherapy in 30 patients with completely resected gastric cancer after D2 lymphadenectomy, highlighting ongoing debates about optimal treatment options.
- Patients received a combination of chemotherapy and radiotherapy, with a specific regimen involving oxaliplatin, folinic acid, and 5-fluorouracil, administered in cycles over several weeks.
- Results showed a relapse rate of 33.3% among patients, while the three-year overall survival rate was 72.7% and disease-free survival rate was 65%, indicating that this treatment approach is feasible for a significant number of patients.